Bayer A.G. stock: contrarian Buy with €35 target. Click for this updated look at BAYZF stock prospects and why I am neutral ...
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
The companies will leverage Bayer's expertise in developing medicines for heart conditions and Soufflé's siRNA delivery technologies to advance the treatment.
U.S. President Donald Trump recently revealed that he has been taking 325 mg of aspirin daily for over 20 years, prompting warnings from medical professionals in the U.S. and South Korea about ...
MedPage Today on MSN

Is Trump's aspirin dose too high?

The president's aspirin use goes against guidelines for primary prevention ...
More than 30 million Americans take the over-the-counter medication aspirin, the two-cent-per-pill drug used to relieve pain and decrease the risk of heart attack and stroke. It is a relatively safe ...
Donald Trump doctor's disclosure about the President's long-term use of high-dose aspirin has put the spotlight on how much aspirin is safe.(Getty Images via AFP) US President Donald Trump’s health ...
President Donald Trump said bruising on his hand is the result of taking a daily dose of aspirin higher than what doctors recommend. In an interview with The Wall Street Journal, Trump said he has ...
Trump on age scrutiny: ‘My health is perfect’ amid fitness concerns During a wide-ranging interview with The Wall Street Journal, President Donald Trump brushed aside concerns about his fitness, ...
Add Yahoo as a preferred source to see more of our stories on Google. Fox News Senior Medical Analyst Marc Siegel downplayed the bruising on President Donald Trump’s hands, calling the development ...
In one of his most candid interviews about his age, President Trump disclosed the ways he manages his health, several of which go against the advice of his doctors. Speaking to The Wall Street Journal ...